# ABIOMED Inc. (ABMD)

Source: https://www.quantisnow.com/company/ABMD
Generated: 2026-11-10T10:16:43.318Z

- Ticker: ABMD
- Exchange: NASDAQ
- Sector: Health Care
- Industry: Medical/Dental Instruments
- Website: abiomed.com

## About

Abiomed, Inc. engages in the research, development, and sale of medical devices to assist or replace the pumping function of the failing heart. It also provides a continuum of care to heart failure patients. The company offers Impella 2.5, a percutaneous micro heart pump with integrated motor and sensors; and Impella CP, a device for use by interventional cardiologists to support patients in the cath lab, as well as by cardiac surgeons in the heart surgery suite. It also provides Impella 5.0, Impella LD, and Impella 5.5, which are percutaneous micro heart pumps with integrated motors and sensors for use primarily in the heart surgery suite; Impella RP, a percutaneous catheter-based axial flow pump; Impella SmartAssist platform that includes optical sensor technology for improved pump positioning and the use of algorithms that enable improved native heart assessment during the weaning process; Impella Connect, a cloud-based technology that enables secure and remote viewing of the Automated Impella Controller for physicians and hospital staffs; and OXY-1 System, a portable external respiratory assistance device. In addition, the company is developing Impella ECP, a pump for blood flow of greater than three liters per minute; Impella XR Sheath, a sheath that expands and recoils allowing small bore access and closure with Impella heart pumps; and Impella BTR, a percutaneous micro heart pump with integrated motors and sensors. Abiomed, Inc. sells its products through direct sales and clinical support personnel in the United States, Japan, Europe, Canada, Latin America, the Asia-Pacific, and the Middle East. The company was founded in 1981 and is headquartered in Danvers, Massachusetts.

## Latest ABMD news and filings

- 2023-07-12 13:00 UTC [Leadership Update] [Dr. Mehdi H. Shishehbor Appointed Chief Medical Officer of Inquis Medical](https://www.quantisnow.com/insight/dr-mehdi-h-shishehbor-appointed-chief-medical-officer-of-inquis-4744973)
- 2023-01-06 11:39 UTC [SEC Schedule 13G] [SEC Form SC 13G/A filed by ABIOMED Inc. (Amendment)](https://www.quantisnow.com/insight/sec-form-sc-13ga-filed-by-abiomed-inc-amendment-3881768)
- 2023-01-03 13:30 UTC [SEC Form 15-12G filed by ABIOMED Inc.](https://www.quantisnow.com/insight/sec-form-15-12g-filed-by-abiomed-inc-3861979)
- 2022-12-29 21:03 UTC [SEC Schedule 13G] [SEC Form SC 13G filed by ABIOMED Inc.](https://www.quantisnow.com/insight/sec-form-sc-13g-filed-by-abiomed-inc-3855377)
- 2022-12-28 01:47 UTC [SEC Form 4] [SEC Form 4: Sutter Martin P returned 123,370 shares to the company, closing all direct ownership in the company](https://www.quantisnow.com/insight/sec-form-4-sutter-martin-p-returned-123370-shares-to-3847964)
- 2022-12-28 01:44 UTC [SEC Form 4] [SEC Form 4: Puhy Dorothy E returned 14,590 shares to the company, closing all direct ownership in the company](https://www.quantisnow.com/insight/sec-form-4-puhy-dorothy-e-returned-14590-shares-to-3847963)
- 2022-12-28 01:41 UTC [SEC Form 4] [SEC Form 4: Trapp Todd A returned 14,166 shares to the company, closing all direct ownership in the company](https://www.quantisnow.com/insight/sec-form-4-trapp-todd-a-returned-14166-shares-to-3847962)
- 2022-12-28 01:37 UTC [SEC Form 4] [SEC Form 4: Plano Matthew T. returned 8,406 units of Common Stock $.01 par value to the company, closing all direct ownership in the company](https://www.quantisnow.com/insight/sec-form-4-plano-matthew-t-returned-8406-units-of-3847961)
- 2022-12-27 22:55 UTC [SEC Form 4] [SEC Form 4: Minogue Michael R returned 410,632 units of Common Stock $.01 par value to the company, closing all direct ownership in the company](https://www.quantisnow.com/insight/sec-form-4-minogue-michael-r-returned-410632-units-of-3847852)
- 2022-12-27 22:50 UTC [SEC Form 4] [SEC Form 4: Greenfield Andrew J returned 23,484 shares to the company, closing all direct ownership in the company](https://www.quantisnow.com/insight/sec-form-4-greenfield-andrew-j-returned-23484-shares-to-3847846)
- 2022-12-27 22:46 UTC [SEC Form 4] [SEC Form 4: Began Marc A returned 12,237 shares to the company, closing all direct ownership in the company](https://www.quantisnow.com/insight/sec-form-4-began-marc-a-returned-12237-shares-to-3847837)
- 2022-12-27 22:29 UTC [SEC Form 4] [SEC Form 4: Johnson Paula A returned 1,659 shares to the company, closing all direct ownership in the company](https://www.quantisnow.com/insight/sec-form-4-johnson-paula-a-returned-1659-shares-to-3847791)
- 2022-12-27 22:27 UTC [SEC Form 4] [SEC Form 4: Rivet Jeannine M was granted 9,285 shares](https://www.quantisnow.com/insight/sec-form-4-rivet-jeannine-m-was-granted-9285-shares-3847778)
- 2022-12-27 22:21 UTC [SEC Form 4] [SEC Form 4: Thomas Paul returned 6,357 shares to the company, closing all direct ownership in the company](https://www.quantisnow.com/insight/sec-form-4-thomas-paul-returned-6357-shares-to-the-3847742)
- 2022-12-27 22:19 UTC [SEC Form 4] [SEC Form 4: Rolle Myron L returned 1,721 shares to the company, closing all direct ownership in the company](https://www.quantisnow.com/insight/sec-form-4-rolle-myron-l-returned-1721-shares-to-3847732)
- 2022-12-27 22:17 UTC [SEC Form 4] [SEC Form 4: Van Gorder Chris was granted 7,410 shares](https://www.quantisnow.com/insight/sec-form-4-van-gorder-chris-was-granted-7410-shares-3847720)
- 2022-12-22 21:46 UTC [SEC Form S-8 POS] [SEC Form S-8 POS filed by ABIOMED Inc.](https://www.quantisnow.com/insight/sec-form-s-8-pos-filed-by-abiomed-inc-3839296)
- 2022-12-22 21:46 UTC [SEC Form S-8 POS] [SEC Form S-8 POS filed by ABIOMED Inc.](https://www.quantisnow.com/insight/sec-form-s-8-pos-filed-by-abiomed-inc-3839285)
- 2022-12-22 21:45 UTC [SEC Form S-8 POS] [SEC Form S-8 POS filed by ABIOMED Inc.](https://www.quantisnow.com/insight/sec-form-s-8-pos-filed-by-abiomed-inc-3839278)
- 2022-12-22 21:44 UTC [SEC Form S-8 POS] [SEC Form S-8 POS filed by ABIOMED Inc.](https://www.quantisnow.com/insight/sec-form-s-8-pos-filed-by-abiomed-inc-3839272)
- 2022-12-22 21:44 UTC [SEC Form S-8 POS] [SEC Form S-8 POS filed by ABIOMED Inc.](https://www.quantisnow.com/insight/sec-form-s-8-pos-filed-by-abiomed-inc-3839265)
- 2022-12-22 21:42 UTC [SEC Form S-8 POS] [SEC Form S-8 POS filed by ABIOMED Inc.](https://www.quantisnow.com/insight/sec-form-s-8-pos-filed-by-abiomed-inc-3839244)
- 2022-12-22 21:40 UTC [SEC Form S-8 POS] [SEC Form S-8 POS filed by ABIOMED Inc.](https://www.quantisnow.com/insight/sec-form-s-8-pos-filed-by-abiomed-inc-3839238)
- 2022-12-22 21:40 UTC [SEC Form S-8 POS] [SEC Form S-8 POS filed by ABIOMED Inc.](https://www.quantisnow.com/insight/sec-form-s-8-pos-filed-by-abiomed-inc-3839231)
- 2022-12-22 21:39 UTC [SEC Form S-8 POS] [SEC Form S-8 POS filed by ABIOMED Inc.](https://www.quantisnow.com/insight/sec-form-s-8-pos-filed-by-abiomed-inc-3839220)
- 2022-12-22 21:38 UTC [SEC Form S-8 POS] [SEC Form S-8 POS filed by ABIOMED Inc.](https://www.quantisnow.com/insight/sec-form-s-8-pos-filed-by-abiomed-inc-3839214)
- 2022-12-22 21:38 UTC [SEC Form S-8 POS] [SEC Form S-8 POS filed by ABIOMED Inc.](https://www.quantisnow.com/insight/sec-form-s-8-pos-filed-by-abiomed-inc-3839211)
- 2022-12-22 21:37 UTC [SEC Form S-8 POS] [SEC Form S-8 POS filed by ABIOMED Inc.](https://www.quantisnow.com/insight/sec-form-s-8-pos-filed-by-abiomed-inc-3839200)
- 2022-12-22 21:37 UTC [SEC Form S-8 POS] [SEC Form S-8 POS filed by ABIOMED Inc.](https://www.quantisnow.com/insight/sec-form-s-8-pos-filed-by-abiomed-inc-3839198)
- 2022-12-22 21:36 UTC [SEC Form S-8 POS] [SEC Form S-8 POS filed by ABIOMED Inc.](https://www.quantisnow.com/insight/sec-form-s-8-pos-filed-by-abiomed-inc-3839189)
- 2022-12-22 21:34 UTC [SEC Form S-8 POS] [SEC Form S-8 POS filed by ABIOMED Inc.](https://www.quantisnow.com/insight/sec-form-s-8-pos-filed-by-abiomed-inc-3839184)
- 2022-12-22 21:34 UTC [SEC Form S-8 POS] [SEC Form S-8 POS filed by ABIOMED Inc.](https://www.quantisnow.com/insight/sec-form-s-8-pos-filed-by-abiomed-inc-3839182)
- 2022-12-22 21:33 UTC [SEC Form S-8 POS] [SEC Form S-8 POS filed by ABIOMED Inc.](https://www.quantisnow.com/insight/sec-form-s-8-pos-filed-by-abiomed-inc-3839174)
- 2022-12-22 21:31 UTC [SEC Form 8-K] [ABIOMED Inc. filed SEC Form 8-K: Completion of Acquisition or Disposition of Assets, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Material Modification to Rights of Security Holders, Changes in Control of Registrant, Leadership Update, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits](https://www.quantisnow.com/insight/abiomed-inc-filed-sec-form-8-k-completion-of-acquisition-or-3839147)
- 2022-12-22 14:14 UTC [SEC Schedule TOT] [SEC Form SC TO-T/A filed by ABIOMED Inc. (Amendment)](https://www.quantisnow.com/insight/sec-form-sc-to-ta-filed-by-abiomed-inc-amendment-3836800)
- 2022-12-22 14:00 UTC [SEC Schedule 14D-9] [SEC Form SC 14D9/A filed by ABIOMED Inc. (Amendment)](https://www.quantisnow.com/insight/sec-form-sc-14d9a-filed-by-abiomed-inc-amendment-3836635)
- 2022-12-21 14:02 UTC [Market Chatter] [Abiomed Announces FDA Approves Impella ECP Pivotal Heart Pump And First Patients Enrolled In Pivotal Clinical Trial](https://www.quantisnow.com/insight/abiomed-announces-fda-approves-impella-ecp-pivotal-heart-pump-and-3831797)
- 2022-12-21 14:00 UTC [FDA Approves Impella ECP Pivotal Heart Pump and First Patients Enrolled in Pivotal Clinical Trial](https://www.quantisnow.com/insight/fda-approves-impella-ecp-pivotal-heart-pump-and-first-patients-3831671)
- 2022-12-20 21:05 UTC [SEC Form 4] [SEC Form 4: Greenfield Andrew J was granted 14 shares, increasing direct ownership by 0.09% to 15,977 units](https://www.quantisnow.com/insight/sec-form-4-greenfield-andrew-j-was-granted-14-shares-3828996)
- 2022-12-20 21:02 UTC [SEC Form 4] [SEC Form 4: Minogue Michael R was granted 1 units of Common Stock $.01 par value, increasing direct ownership by 0.00% to 136,086 units](https://www.quantisnow.com/insight/sec-form-4-minogue-michael-r-was-granted-1-units-3828900)

## More

- Live page with ratings, short volume, options and peers: https://www.quantisnow.com/company/ABMD
- Earnings history: https://www.quantisnow.com/earnings/ABMD
- Dividend history: https://www.quantisnow.com/dividends/ABMD
- Insider transactions: https://www.quantisnow.com/insiders/ABMD
- Options chain: https://www.quantisnow.com/options/ABMD
- SEC 8-K filings only: https://www.quantisnow.com/company/ABMD/8-k
- RSS and alerts for ABMD: https://www.quantisnow.com/docs/rss-feeds.md